Study to Reduce Intravenous Exposures (STRIVE)

Completed · Phase 2/Phase 3

Conditions studied: Hepatitis C, HIV Infections

In brief

The purpose of this study is to determine whether a six-session, small group behavioral intervention based on "peer-volunteer activism" is effective in (1) decreasing distributive sharing of syringes and other injection paraphernalia and (2) increasing utilization of HCV-related healthcare services among HCV-infected injection drug users

Key facts

Study ID

NCT00391482

Run by

National Institute on Drug Abuse (NIDA)

People needed

750

Starts

2002-06-01

Expected to finish

2005-02-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HCV antibody positive
• age between 18 and 35 years old;
• reported injection drug use in the past 6 months
• willing to provide a blood sample for liver function testing

You may not qualify if…

• HIV antibody positive
• planned on moving from city within the next 12 months;
• unable to comprehend English well enough to complete English-only assessments and group sessions

Where it is running

• Johns Hopkins University, Bloomberg School of Public Health — Baltimore, Maryland, United States
• New York Academy of Medicine, Center for Urban Epidemiologic Studies — New York, New York, United States
• Public Health Seattle & King County — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.